VXRT Oct 2024 1.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:41AM EDT. Market open.
| Previous close | 0.4400 |
| Open | 0.5500 |
| Bid | 0.2000 |
| Ask | 0.6000 |
| Strike | 1.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.4400 - 0.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 107 |
- GuruFocus.com
Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...
Explore key financial outcomes, clinical trial updates, and strategic plans from Vaxart's latest earnings call.
GlobeNewswireVaxart Provides Business Update and Reports First Quarter 2024 Financial Results
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart’s oral pill XBB COVID-19 vaccine against an approved mRNA vaccine comparator as early as the second quarter of 2024 Anticipates meeting with the FDA in mid-2024 to evaluate clinical data and discuss next steps for its norovirus program Conference call today a
© 2024 Yahoo. All rights reserved.